Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesLipoxin A4 reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of NF-kB activation
Journal of Pharmacology and Experimental Therapeutics, 11/25/09
Kure I et al. – The results indicate that LXA4 exerts anti–inflammatory effects through inhibition of NF–kB activation, and therefore, LXA4 may be useful as a therapeutic strategy against intestinal mucosa inflammation.
Related Articles
Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model
Allergy, 11/17/09
Relevance Score: 83%
Lipoxin A4 Metabolites/Analogues from Two Commercial Sources have No Effects on TNF-alpha-mediated Priming or Activation through the Neutrophil Formyl Peptide Receptors
Scandinavian Journal of Immunology, 10/01/09
Relevance Score: 83%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of the DRY Motif and the Missing "Ionic Lock" on Constitutive Activity and G-Protein-Coupling of the Human Histamine H4 Receptor
Journal of Pharmacology and Experimental Therapeutics, 02/09/10
Cannabinoid inhibition of macrophage migration to the tat protein of hiv-1 is linked to the cb2 cannabinoid receptor
Journal of Pharmacology and Experimental Therapeutics, 02/09/10
Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant Stat3 and EGFR or Src
Journal of Pharmacology and Experimental Therapeutics, 02/09/10
Article Search
Sponsor
Sponsor